BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11118299)

  • 1. EWS fli-1 antisense nanocapsules inhibits ewing sarcoma-related tumor in mice.
    Lambert G; Bertrand JR; Fattal E; Subra F; Pinto-Alphandary H; Malvy C; Auclair C; Couvreur P
    Biochem Biophys Res Commun; 2000 Dec; 279(2):401-6. PubMed ID: 11118299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells.
    Tanaka K; Iwakuma T; Harimaya K; Sato H; Iwamoto Y
    J Clin Invest; 1997 Jan; 99(2):239-47. PubMed ID: 9005992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro.
    Kovar H; Aryee DN; Jug G; Henöckl C; Schemper M; Delattre O; Thomas G; Gadner H
    Cell Growth Differ; 1996 Apr; 7(4):429-37. PubMed ID: 9052984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the EWS/FLI-1 fusion transcript specific for Ewing sarcoma and peripheral primitive neuroectodermal tumor? A report of four cases showing this transcript in a wider range of tumor types.
    Thorner P; Squire J; Chilton-MacNeil S; Marrano P; Bayani J; Malkin D; Greenberg M; Lorenzana A; Zielenska M
    Am J Pathol; 1996 Apr; 148(4):1125-38. PubMed ID: 8644855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene.
    Lessnick SL; Braun BS; Denny CT; May WA
    Oncogene; 1995 Feb; 10(3):423-31. PubMed ID: 7845667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts.
    Ouchida M; Ohno T; Fujimura Y; Rao VN; Reddy ES
    Oncogene; 1995 Sep; 11(6):1049-54. PubMed ID: 7566963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EWS/Fli-1 chimeric protein is a transcriptional activator.
    Ohno T; Rao VN; Reddy ES
    Cancer Res; 1993 Dec; 53(24):5859-63. PubMed ID: 7503813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined transcriptional and translational targeting of EWS/FLI-1 in Ewing's sarcoma.
    Mateo-Lozano S; Gokhale PC; Soldatenkov VA; Dritschilo A; Tirado OM; Notario V
    Clin Cancer Res; 2006 Nov; 12(22):6781-90. PubMed ID: 17121899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias.
    Yi H; Fujimura Y; Ouchida M; Prasad DD; Rao VN; Reddy ES
    Oncogene; 1997 Mar; 14(11):1259-68. PubMed ID: 9178886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation and forced expression of EWS-Fli1 fusion gene results in changes in the expression of G(1)regulatory genes.
    Matsumoto Y; Tanaka K; Nakatani F; Matsunobu T; Matsuda S; Iwamoto Y
    Br J Cancer; 2001 Mar; 84(6):768-75. PubMed ID: 11259090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors.
    Castillero-Trejo Y; Eliazer S; Xiang L; Richardson JA; Ilaria RL
    Cancer Res; 2005 Oct; 65(19):8698-705. PubMed ID: 16204038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties.
    Bertolotti A; Bell B; Tora L
    Oncogene; 1999 Dec; 18(56):8000-10. PubMed ID: 10637511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential down-regulation of phospholipase C-beta in Ewing's sarcoma cells transfected with antisense EWS-Fli-1.
    Dohjima T; Ohno T; Banno Y; Nozawa Y; Wen-yi Y; Shimizu K
    Br J Cancer; 2000 Jan; 82(1):16-9. PubMed ID: 10638960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo potentialities of EWS-Fli-1 targeted antisense oligonucleotides-nanospheres complexes.
    Maksimenko A; Polard V; Villemeur M; Elhamess H; Couvreur P; Bertrand JR; Aboubakar M; Gottikh M; Malvy C
    Ann N Y Acad Sci; 2005 Nov; 1058():52-61. PubMed ID: 16394125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma.
    Fukuma M; Okita H; Hata J; Umezawa A
    Oncogene; 2003 Jan; 22(1):1-9. PubMed ID: 12527902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense oligonucleotide nanocapsules efficiently inhibit EWS-Fli1 expression in a Ewing's sarcoma model.
    Toub N; Bertrand JR; Malvy C; Fattal E; Couvreur P
    Oligonucleotides; 2006; 16(2):158-68. PubMed ID: 16764539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fli-1 (Friend leukemia integration 1). Oncogene].
    Bull Cancer; 1998 Oct; 85(10):830. PubMed ID: 9867365
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor cells are present in stem cell harvests of Ewings sarcoma patients and their persistence following transplantation is associated with relapse.
    Yaniv I; Cohen IJ; Stein J; Zilberstein J; Liberzon E; Atlas O; Grunshpan A; Sverdlov Y; Ash S; Zaizov R; Avigad S
    Pediatr Blood Cancer; 2004 May; 42(5):404-9. PubMed ID: 15049010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.
    Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL
    Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biology of EWS/FLI and related fusion genes in Ewing's sarcoma and primitive neuroectodermal tumor.
    May WA; Denny CT
    Curr Top Microbiol Immunol; 1997; 220():143-50. PubMed ID: 9103680
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.